Review of X-Linked Syndromes with Arthrogryposis Or Early Contractures—Aid to Diagnosis and Pathway Identification Jesse M
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Centronuclear Myopathies Under Attack: a Plethora of Therapeutic Targets Hichem Tasfaout, Belinda Cowling, Jocelyn Laporte
CORE Metadata, citation and similar papers at core.ac.uk Provided by Archive Ouverte en Sciences de l'Information et de la Communication Centronuclear myopathies under attack: A plethora of therapeutic targets Hichem Tasfaout, Belinda Cowling, Jocelyn Laporte To cite this version: Hichem Tasfaout, Belinda Cowling, Jocelyn Laporte. Centronuclear myopathies under attack: A plethora of therapeutic targets. Journal of Neuromuscular Diseases, IOS Press, 2018, 5, pp.387 - 406. 10.3233/JND-180309. hal-02438924 HAL Id: hal-02438924 https://hal.archives-ouvertes.fr/hal-02438924 Submitted on 14 Jan 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Journal of Neuromuscular Diseases 5 (2018) 387–406 387 DOI 10.3233/JND-180309 IOS Press Review Centronuclear myopathies under attack: A plethora of therapeutic targets Hichem Tasfaouta,b,c,d, Belinda S. Cowlinga,b,c,d,1 and Jocelyn Laportea,b,c,d,1,∗ aDepartment of Translational Medicine and Neurogenetics, Institut de G´en´etique et de Biologie Mol´eculaire et Cellulaire (IGBMC), Illkirch, France bInstitut National de la Sant´eetdelaRechercheM´edicale (INSERM), U1258, Illkirch, France cCentre National de la Recherche Scientifique (CNRS), UMR7104, Illkirch, France dUniversit´e de Strasbourg, Illkirch, France Abstract. -
Reframing Psychiatry for Precision Medicine
Reframing Psychiatry for Precision Medicine Elizabeth B Torres 1,2,3* 1 Rutgers University Department of Psychology; [email protected] 2 Rutgers University Center for Cognitive Science (RUCCS) 3 Rutgers University Computer Science, Center for Biomedicine Imaging and Modelling (CBIM) * Correspondence: [email protected]; Tel.: (011) +858-445-8909 (E.B.T) Supplementary Material Sample Psychological criteria that sidelines sensory motor issues in autism: The ADOS-2 manual [1, 2], under the “Guidelines for Selecting a Module” section states (emphasis added): “Note that the ADOS-2 was developed for and standardized using populations of children and adults without significant sensory and motor impairments. Standardized use of any ADOS-2 module presumes that the individual can walk independently and is free of visual or hearing impairments that could potentially interfere with use of the materials or participation in specific tasks.” Sample Psychiatric criteria from the DSM-5 [3] that does not include sensory-motor issues: A. Persistent deficits in social communication and social interaction across multiple contexts, as manifested by the following, currently or by history (examples are illustrative, not exhaustive, see text): 1. Deficits in social-emotional reciprocity, ranging, for example, from abnormal social approach and failure of normal back-and-forth conversation; to reduced sharing of interests, emotions, or affect; to failure to initiate or respond to social interactions. 2. Deficits in nonverbal communicative behaviors used for social interaction, ranging, for example, from poorly integrated verbal and nonverbal communication; to abnormalities in eye contact and body language or deficits in understanding and use of gestures; to a total lack of facial expressions and nonverbal communication. -
Reorganisation of the Visual Cortex in Callosal Agenesis and Colpocephaly
Journal of Clinical Neuroscience (2000) 7(1), 13–15 © 2000 Harcourt Publishers Ltd DOI: 10.1054/ jocn.1998.0105, available online at http://www.idealibrary.com on Clinical study Reorganisation of the visual cortex in callosal agenesis and colpocephaly Richard G. Bittar1,2 MB BS, Alain Ptito1 PHD, Serge O. Dumoulin1, Frederick Andermann1 MD FRCP(C), David C. Reutens1 MD FRACP 1Montreal Neurological Institute and Hospital and Department of Neurology and Neurosurgery, McGill University, Montreal, Canada 2Department of Anatomy and Histology, University of Sydney, Australia Summary Structural defects involving eloquent regions of the cerebral cortex may be accompanied by abnormal localisation of function. Using functional magnetic resonance imaging (fMRI), we studied the organisation of the visual cortex in a patient with callosal agenesis and colpocephaly, whose visual acuity and binocular visual fields were normal. The stimulus used was a moving grating confined to one hemifield, on a background of moving dots. In addition to activation patterns elicited by stimulation of each hemifield in the patient, the activation pattern was compared to that seen in six normal volunteers. fMRI demonstrated large scale reorganisation of visual cortical areas in the left hemisphere, and fewer activation foci were observed in both occipital lobes when compared with normal subjects. © 2000 Harcourt Publishers Ltd Keywords: functional magnetic resonance imaging, vision, colpocephaly, callosal agenesis, reorganisation INTRODUCTION showed interictal slow wave activity throughout the right hemi- sphere and seizures with onset in the right temporo-frontal region. An exciting application of non-invasive functional brain mapping Ictal Tc99m HMPAO single photon emission computed tomography techniques such as functional magnetic resonance imaging (fMRI) (SPECT) revealed a diffuse increase in perfusion within the right is the study of cortical sensory and motor reorganisation following cerebral hemisphere. -
PLAGIOCEPHALY and CRANIOSYNOSTOSIS TREATMENT Policy Number: ORT010 Effective Date: February 1, 2019
UnitedHealthcare® Commercial Medical Policy PLAGIOCEPHALY AND CRANIOSYNOSTOSIS TREATMENT Policy Number: ORT010 Effective Date: February 1, 2019 Table of Contents Page COVERAGE RATIONALE ............................................. 1 CENTERS FOR MEDICARE AND MEDICAID SERVICES DEFINITIONS .......................................................... 1 (CMS) .................................................................... 6 APPLICABLE CODES ................................................. 2 REFERENCES .......................................................... 6 DESCRIPTION OF SERVICES ...................................... 2 POLICY HISTORY/REVISION INFORMATION ................. 7 CLINICAL EVIDENCE ................................................ 4 INSTRUCTIONS FOR USE .......................................... 7 U.S. FOOD AND DRUG ADMINISTRATION (FDA) ........... 6 COVERAGE RATIONALE The following are proven and medically necessary: Cranial orthotic devices for treating infants with the following conditions: o Craniofacial asymmetry with severe (non-synostotic) positional plagiocephaly when ALL of the following criteria are met: . Infant is between 3-18 months of age . Severe plagiocephaly is present with or without torticollis . Documentation of a trial of conservative therapy of at least 2 months duration with cranial repositioning, with or without stretching therapy o Craniosynostosis (i.e., synostotic plagiocephaly) following surgical correction Cranial orthotic devices used for treating infants with mild to moderate plagiocephaly -
The Epidemiology of the Cerebral Palsies
Clinics in Developmental Medicine No. 87 The Epidemiology of the Cerebral Palsies Edited by FIONA STANLEY EVA ALBERMAN 1984 Spastics International Medical Publications OXFORD: Blackwell Scientific Publications Ltd. PHILADELPHIA: J. B. Lippincott Co. CHAPTER 11 Prenatal and Perinatal Risk Factors in a Survey of 681 Swedish Cases BENGT and GUDRUN HAGBERG I, that am curtail'd of this fair proportion, Cheated of feature by dissembling nature, , Deform'd, unfinish'd, sent before my time Into this breathing world, scarce half made up, And that so lamely and unfashionable That dogs bark at me, as I halt by them. Shakespeare, Richard III Introduction The aim of this chapter is to try and shed light on more specific aspects of the main groups of prenatal causes and risk factors for cerebral palsy, their mutual importance, and particularly their relationship to superimposed detrimental perinatal events. This survey is based on an investigation of 681 cases born in Sweden from 1959 to 1976. In our original retrospective analysis of causes of cerebral palsy (Hagberg et al. 1975a), it was found necessary to make certain generalisations about the aetiological groupings. Only the risk factor that was considered to be the predominating possible cause was used for classification. There is no doubt that this oversimplifies the issue as it neglects the complex network of different interacting detrimental risk factors that are present in the majority of cases, and in all probability underlie the development of brain lesions. Definitions For the purpose of the Swedish investigation, the following definition of cerebral palsy was used: a non-progressive 'disorder of movement and posture due to a defect or lesion of the immature brain' (Bax 1964). -
Affected Female Carriers of MTM1 Mutations Display a Wide Spectrum
Acta Neuropathol DOI 10.1007/s00401-017-1748-0 ORIGINAL PAPER Afected female carriers of MTM1 mutations display a wide spectrum of clinical and pathological involvement: delineating diagnostic clues Valérie Biancalana1,2,3,4,5 · Sophie Scheidecker1 · Marguerite Miguet1 · Annie Laquerrière6 · Norma B. Romero7,8 · Tanya Stojkovic8 · Osorio Abath Neto9 · Sandra Mercier10,11,12 · Nicol Voermans13 · Laura Tanner14 · Curtis Rogers15 · Elisabeth Ollagnon‑Roman16 · Helen Roper17 · Célia Boutte18 · Shay Ben‑Shachar19 · Xavière Lornage2,3,4,5 · Nasim Vasli2,3,4,5 · Elise Schaefer20 · Pascal Laforet21 · Jean Pouget22 · Alexandre Moerman23 · Laurent Pasquier24 · Pascale Marcorelle25,26 · Armelle Magot12 · Benno Küsters27 · Nathalie Streichenberger28 · Christine Tranchant29 · Nicolas Dondaine1 · Raphael Schneider2,3,4,5,30 · Claire Gasnier1 · Nadège Calmels1 · Valérie Kremer31 · Karine Nguyen32 · Julie Perrier12 · Erik Jan Kamsteeg33 · Pierre Carlier34 · Robert‑Yves Carlier35 · Julie Thompson30 · Anne Boland36 · Jean‑François Deleuze36 · Michel Fardeau7,8 · Edmar Zanoteli9 · Bruno Eymard21 · Jocelyn Laporte2,3,4,5 Received: 9 May 2017 / Revised: 24 June 2017 / Accepted: 2 July 2017 © Springer-Verlag GmbH Germany 2017 Abstract X-linked myotubular myopathy (XLMTM), a females and to delineate diagnostic clues, we character- severe congenital myopathy, is caused by mutations in the ized 17 new unrelated afected females and performed a MTM1 gene located on the X chromosome. A majority of detailed comparison with previously reported cases at the afected males die in the early postnatal period, whereas clinical, muscle imaging, histological, ultrastructural and female carriers are believed to be usually asymptomatic. molecular levels. Taken together, the analysis of this large Nevertheless, several afected females have been reported. cohort of 43 cases highlights a wide spectrum of clini- To assess the phenotypic and pathological spectra of carrier cal severity ranging from severe neonatal and generalized weakness, similar to XLMTM male, to milder adult forms. -
A Novel Locus for Brachydactyly Type A1 on Chromosome 5P13.3-P13.2 C M Armour, M E Mccready, a Baig,Agwhunter, D E Bulman
186 LETTERS TO JMG J Med Genet: first published as 10.1136/jmg.39.3.189 on 1 March 2002. Downloaded from A novel locus for brachydactyly type A1 on chromosome 5p13.3-p13.2 C M Armour, M E McCready, A Baig,AGWHunter, D E Bulman ............................................................................................................................. J Med Genet 2002;39:186–189 he brachydactylies are a group of inherited disorders METHODS characterised by shortened or malformed digits that are The linkage study comprised 34 members including 20 Tthought to be the result of abnormal growth of the affected subjects and was conducted after approval by the phalanges and/or metacarpals. First classified by Bell into Children’s Hospital of Eastern Ontario Ethics Review Com- types A, B, C, D, and E, they were reclassified by Temtamy and mittee. McKusick1 and Fitch.2 Brachydactyly type A1 (BDA1, MIM Peripheral blood samples were taken with informed 112500) is characterised by shortened or absent middle consent from all participating family members, and a stand- phalanges. Often the second and fifth digits, as well as the first ard protocol was used to isolate DNA. A genome wide scan proximal phalanx, are the most severely affected. In addition, was initiated using 36 primer sets from the MAPPAIRS™ all of the small tubular bones tend to be reduced in size and microsatellite markers (Research Genetics, Huntsville, Ala- the metacarpals may be shortened, particularly the fifth bama), encompassing markers from 16 chromosomes. metacarpal. Radial/ulnar clinodactyly, as well as malformed or Particular emphasis was placed on markers from chromo- 11 absent epiphyses, have also been reported.12 Complex some 5 and 17, based on the report by Fukushima et al syndromes have been described in which BDA1 is one of a describing a translocation between 5q11.2 and 17q23 in a girl number of manifestations.3 with Klippel-Feil anomaly and BDA1. -
Arthrogryposis Multiplex Congenita
American Research Journal of Pediatrics Volume 2, Issue 1, pp: 1-5 Research Article Open Access Arthrogryposis Multiplex Congenita – Case Report Faton Krasniqi1, Shpetim Salihu1, Isabere Krasniqi3, Edmond Pistulli2* 1University Clinical Center of Kosova- Neonatology Clinic, Prishtina 2Faculty of Technical Medical Sciences, University of Medicine, Tirana-Albania 3Main Head Family Center, Prishtina-Kosovo *[email protected] Abstract: Arthrogryposis multiplex congenita is a rare disorder that accompanies with multiple joint been reported from Asia, Africa and Europe. Incidence is about 1:3000 to 1:10.000 of all live newborns. The contractures, which can occur at delivery and are non progressive. It affects both sexes. Most of the cases have causes, for now are unknown. However, this disorder can be provoked from neuropathic and myopathic diseases or some another cause that decreases the mobility of fetal joints. Great joints of both extremities are more attacked. The muscles of the extremities that are attacked can be hypoplastic. Also, the IQ of these children multiplex congenita, that has been resuscitated in delivery room and endotracheal intubation was needed. can be affected. We have presented a newborn female, born in term, by normal delivery, with arthrogryposis In utero, there has been a suspicion from the gynecologists at the end of pregnancy, for esophageal atresia. After delivery, all the needed consults and examinations have been realized. After three weeks in Neonatal Intensive Care Unit, the baby has been discharged in a better general condition, with recommendations to further consultations with orthopedics, physiatrician and pediatrician-neurologists. Key words: arthrogryposis, multiple contractures of joints, congenital defect Introduction Arthrogryposis multiplex congenita refers to a heterogeneous group of congenital defects that manifests with multiple joint contractures (1). -
Sensory Deficits in a Mouse Model of Christianson Syndrome Tarheen
Sensory Deficits in a Mouse Model of Christianson Syndrome Tarheen Fatima Department of Physiology McGill University, Montreal April 2019 A thesis submitted to McGill University in partial fulfillment of the requirements of the degree of Master of Science. © Tarheen Fatima 2019 Abstract Christianson Syndrome (CS) is a recently characterized X-linked neurodevelopmental disorder caused by loss-of-function mutations in the gene slc9a6, encoding the endosomal Na+/H+ Exchanger 6 (NHE6). The disorder is associated with developmental delay, intellectual disability, loss of motor coordination, mutism, ataxia, epilepsy, as well as autistic features. In addition to these symptoms, CS patients exhibit elevated pain thresholds to noxious stimuli as well as discomfort at normally innocuous stimuli. The underlying causes of these sensory deficits are yet to be determined. Hence, this study aims at understanding how loss-of-function of NHE6 affects transmission and processing of pain. To this end, we examined the expression of NHE6 in peripheral and central neurons implicated in sensation and interpretation of pain. Additionally, we characterized the nociceptive behaviour of NHE6 knockout (KO) mice using a battery of behaviour tests. Our immunohistochemical experiments demonstrate that NHE6 is highly expressed in nociceptive, small-diameter dorsal root ganglia (DRG) neurons. Moreover, mice lacking NHE6 display decreased responses to noxious mechanical, thermal and chemical stimuli but are more responsive to noxious cold than wild-type littermates. Interestingly, immunohistochemical characterization of DRG tissue from aged NHE6 null mice indicates a decrease in some neuronal subsets suggesting cell death. Finally, using light brush-induced Fos activation in the dorsal horn, we found that the spinal processing of innocuous stimuli is not different between wildtype and NHE6 knockout mice. -
Practitioners' Section
407 408 GENETICS OF MENTAL RETARDATION [2] [4] PRACTITIONERS’ SECTION epiphenomena. A specific cause for mental a group heritability of 0.49. The aetiology of retardation can be identified in approximately idiopathic mental retardation is usually 80% of people with SMR (IQ<50) and 50% of explained in terms of the ‘polygenic GENETICS OF MENTAL RETARDATION people with MMR (IQ 50–70). multifactorial model.’ The difficulty is that there A. S. AHUJA, ANITA THAPAR, M. J. OWEN are too few studies to provide sufficiently In this article, we will begin by considering precise estimates of the likely role of genes ABSTRACT what is known about the genetics of idiopathic and environment in determining idiopathic mental retardation and then move onto discuss mental retardation. Given the dearth of Mental retardation can follow any of the biological, environmental and psychological events that are capable of producing deficits in cognitive functions. specific genetic causes of mental retardation. published literature we are reliant on Recent advances in molecular genetic techniques have enabled us to understand attempting to draw conclusions from family and more about the molecular basis of several genetic syndromes associated with mental Search methodology twin studies, most of which are very old and retardation. In contrast, where there is no discrete cause, the interplay of genetic Electronic searching was done and the which report widely varying recurrence risks.[5] and environmental influences remains poorly understood. This article presents a relevant studies were identified by searching Recent studies of MMR have shown high rates critical review of literature on genetics of mental retardation. -
Colpocephaly Diagnosed in a Neurologically Normal Adult in the Emergency Department
CASE REPORT Colpocephaly Diagnosed in a Neurologically Normal Adult in the Emergency Department Christopher Parker, DO University of Illinois College of Medicine, Department of Emergency Medicine, Wesley Eilbert, MD Chicago, Illinois Timothy Meehan, MD Christopher Colbert, DO Section Editor: Rick A. McPheeters, DO Submission history: Submitted July 25, 2019; Revision received September 18, 2019; Accepted September 26, 2019 Electronically published October 21, 2019 Full text available through open access at http://escholarship.org/uc/uciem_cpcem DOI: 10.5811/cpcem.2019.9.44646 Colpocephaly is a form of congenital ventriculomegaly characterized by enlarged occipital horns of the lateral ventricles with associated neurologic abnormalities. The diagnosis of colpocephaly is typically made in infancy. Its diagnosis in adulthood without associated clinical symptoms is exceptionally rare. We report a case of colpocephaly diagnosed incidentally in an adult without neurologic abnormalities in the emergency department. To our knowledge, this is only the ninth reported case in an asymptomatic adult and the first to be described in the emergency medicine literature. [Clin Pract Cases Emerg Med. 2019;3(4):421–424.] INTRODUCTION been treated at four different EDs in the two weeks prior to Colpocephaly is a rare form of congenital presentation for the headaches, but no imaging studies had ventriculomegaly often associated with partial or been performed. The patient had no psychiatric history. His complete agenesis of the corpus callosum. Diagnosis is highest level of education was a high school diploma, and typically made in infancy due to associated neurological he was unemployed. and neurodevelopmental disorders.1,2 Initial discovery On arrival, the patient was afebrile with pulse, blood in adulthood is exceedingly rare.3-9 When identified pressure, and respiratory rate all within the normal range. -
Cerebral Palsy the ABC's of CP
Cerebral Palsy The ABC’s of CP Toni Benton, M.D. Continuum of Care Project UNM HSC School of Medicine April 20, 2006 Cerebral Palsy Outline I. Definition II. Incidence, Epidemiology and Distribution III. Etiology IV. Types V. Medical Management VI. Psychosocial Issues VII. Aging Cerebral Palsy-Definition Cerebral palsy is a symptom complex, (not a disease) that has multiple etiologies. CP is a disorder of tone, posture or movement due to a lesion in the developing brain. Lesion results in paralysis, weakness, incoordination or abnormal movement Not contagious, no cure. It is static, but it symptoms may change with maturation Cerebral Palsy Brain damage Occurs during developmental period Motor dysfunction Not Curable Non-progressive (static) Any regression or deterioration of motor or intellectual skills should prompt a search for a degenerative disease Therapy can help improve function Cerebral Palsy There are 2 major types of CP, depending on location of lesions: Pyramidal (Spastic) Extrapyramidal There is overlap of both symptoms and anatomic lesions. The pyramidal system carries the signal for muscle contraction. The extrapyramidal system provides regulatory influences on that contraction. Cerebral Palsy Types of brain damage Bleeding Brain malformation Trauma to brain Lack of oxygen Infection Toxins Unknown Epidemiology The overall prevalence of cerebral palsy ranges from 1.5 to 2.5 per 1000 live births. The overall prevalence of CP has remained stable since the 1960’s. Speculations that the increased survival of the VLBW preemies would cause a rise in the prevalence of CP have proven wrong. Likewise the expected decrease in CP as a result of C-section and fetal monitoring has not happened.